Heart Health ALC may improve cardiovascular health by enhancing energy production in heart cells and reducing oxidative stress, though more research is needed in this area
Key risk factors include: History of pancreatitis caution is advised in patients with previous pancreatitis Pre-existing gastrointestinal disease particularly severe gastroparesis or severe GORD Gallbladder disease rapid weight loss itself increases gallstone risk Concurrent medications particularly NSAIDs, anticoagulants, or other drugs affecting gastric mucosa Helicobacter pylori infection if present, may increase ulcer risk independently Diabetic gastroparesis in patients with diabetes, pre-existing delayed gastric emptying may be exacerbated It should be noted that animal studies have shown an increased incidence of thyroid C-cell tumours with semaglutide, though the clinical relevance to humans is unknown
Customizing your own GHK-Cu collection ensures your brand stays at the forefront of advanced peptide science and regenerative beauty
Comparative Efficacy: Weight Loss Outcomes (SURMOUNT vs STEP) There are no published head-to-head clinical trials comparing semaglutide and tirzepatide directly
PlexusDx uses biomarker and genetic context to help explain why onset varies, supporting precision conversations about your treatment plan
Research on GLP-1 receptors in the brain has suggested potential roles in learning, memory, and mood regulation (Durante et al., 2013